Covenant Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $539K | Hold |
1,329
| – | – | 0.16% | 68 |
|
2025
Q1 | $661K | Hold |
1,329
| – | – | 0.21% | 54 |
|
2024
Q4 | $691K | Hold |
1,329
| – | – | 0.21% | 59 |
|
2024
Q3 | $822K | Hold |
1,329
| – | – | 0.24% | 60 |
|
2024
Q2 | $735K | Hold |
1,329
| – | – | 0.22% | 63 |
|
2024
Q1 | $772K | Hold |
1,329
| – | – | 0.23% | 61 |
|
2023
Q4 | $705K | Hold |
1,329
| – | – | 0.22% | 70 |
|
2023
Q3 | $673K | Hold |
1,329
| – | – | 0.24% | 70 |
|
2023
Q2 | $693K | Sell |
1,329
-108
| -8% | -$56.3K | 0.25% | 66 |
|
2023
Q1 | $828K | Sell |
1,437
-235
| -14% | -$135K | 0.32% | 50 |
|
2022
Q4 | $921K | Hold |
1,672
| – | – | 0.37% | 40 |
|
2022
Q3 | $848K | Sell |
1,672
-93
| -5% | -$47.2K | 0.41% | 38 |
|
2022
Q2 | $959K | Buy |
1,765
+93
| +6% | +$50.5K | 0.44% | 37 |
|
2022
Q1 | $988K | Hold |
1,672
| – | – | 0.39% | 43 |
|
2021
Q4 | $1.12M | Hold |
1,672
| – | – | 0.41% | 50 |
|
2021
Q3 | $955K | Hold |
1,672
| – | – | 0.38% | 53 |
|
2021
Q2 | $843K | Hold |
1,672
| – | – | 0.32% | 66 |
|
2021
Q1 | $763K | Sell |
1,672
-383
| -19% | -$175K | 0.3% | 70 |
|
2020
Q4 | $957K | Hold |
2,055
| – | – | 0.41% | 58 |
|
2020
Q3 | $907K | Sell |
2,055
-81
| -4% | -$35.8K | 0.44% | 48 |
|
2020
Q2 | $774K | Hold |
2,136
| – | – | 0.36% | 64 |
|
2020
Q1 | $606K | Hold |
2,136
| – | – | 0.32% | 69 |
|
2019
Q4 | $694K | Sell |
2,136
-1
| -0% | -$325 | 0.32% | 72 |
|
2019
Q3 | $622K | Hold |
2,137
| – | – | 0.33% | 71 |
|
2019
Q2 | $628K | Buy |
2,137
+1
| +0% | +$294 | 0.33% | 74 |
|
2019
Q1 | $585K | Buy |
+2,136
| New | +$585K | 0.33% | 75 |
|